Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status.
Journal: Breast cancer (Tokyo, Japan)
Published: March 14, 2024
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.
Journal: The oncologist
Published: December 27, 2022
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 21, 2021
Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 15, 2014
The utility of restaging bone marrow biopsy in PET-negative patients with diffuse large B-cell lymphoma and baseline bone marrow involvement.
Journal: American journal of hematology
Published: March 14, 2014
41-year-old woman with fever, neutropenia, and elevated transaminase levels.
Journal: Mayo Clinic proceedings
Published: April 12, 2012
Androgen deprivation therapy-associated vasomotor symptoms.
Journal: Asian journal of andrology
Published: January 31, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026